GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids: drug may prevent transplant complications
Disease control Not yet recruitingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who are getting a bone marrow transplant. GVHD is a serious complication where donor cells…
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Jun 16, 2026 22:20 UTC
-
Can patients safely stop Anti-Rejection meds sooner after transplant?
Disease control Not yet recruitingThis study tests whether it is safe and feasible for certain patients to stop taking tacrolimus, an anti-rejection drug, early after a stem cell transplant. The goal is to reduce side effects while still preventing graft-versus-host disease (GVHD). About 50 adults with blood canc…
Matched conditions: GVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New blood test could predict transplant complications
Knowledge-focused Not yet recruitingThis study tests a new way to measure special immune cells (iNKT cells) in the blood of 75 people who have had a stem cell transplant for leukemia. The goal is to see if these cell levels can help predict serious complications like graft-versus-host disease (GvHD) or relapse. Par…
Matched conditions: GVHD
Sponsor: University Hospital Pilsen • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC